Researchers at the University of Manchester found that flare-ups in chronic obstructive pulmonary disease can be reduced by 20% with a combined triple inhaler. The team’s work was published in the Lancet.
The 2,691-patient trial compared an inhaler that delivers 3 different compounds to a commonly-used inhaler. Another sub-set of patients were administered a triple combination therapy in 2 inhalers.
Get the full story at our sister site, Drug Delivery Business News.
The post Triple inhaler reduces COPD flare-ups by 20% appeared first on MassDevice.